Selank 10mg (HPLC-Verified / Batch COA)⁠

Selank Research Reagent | Regulatory Heptapeptide Analogue

Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Structurally, it is a modified analogue of the naturally occurring tetrapeptide tuftsin (Thr-Lys-Pro-Arg), featuring a C-terminal Pro-Gly-Pro stabilization sequence. This structural addition protects the underlying peptide from rapid enzymatic degradation by blood peptidases, making it an exceptionally reliable asset for sustained in vitro tracking and cellular mapping.

In neurological research models, Selank acts as a targeted neuromodulator. It is widely investigated for its capacity to influence the metabolism of monoamine neurotransmitters (including serotonin and dopamine) and alter the expression of Brain-Derived Neurotrophic Factor (BDNF) within hippocampal tissue cultures. This specialized profile enables researchers to isolate and observe unique signaling dynamics without inducing broad-spectrum sedative side effects.

Batch-Specific HPLC Analysis & Validation

To ensure strict laboratory reproducibility and eliminate analytical errors across your experimental timeline, this reagent complies with comprehensive quality control checkpoints:

• HPLC Spectral Characterization: Every batch is rigorously tested via High-Performance Liquid Chromatography to guarantee an absolute chemical purity threshold of ≥99.0%.
• Mass Spectrometry Verification: Authenticates correct molecular mass parameters, ensuring zero presence of raw chemical fragments or unlinked amino chains.
• Batch-Linked COA: Reagents are issued with verifiable Certificate of Analysis documentation to maintain absolute laboratory transparency.

Experimental Research Context & Mechanisms

Preclinical investigation utilizing Selank 10mg focus extensively on several key physiological and cellular vectors:

• Enkephalin Degradation Inhibition: Research indicates Selank blocks enkephalin-degrading enzymes present in blood plasma, potentially prolonging the activity of endogenous regulatory pathways.
• Neuroplasticity & Neurogenesis: Assessing how the up-regulation of neurotrophins like BDNF impacts synaptic plasticity and cellular preservation under toxic culture environments.
• GABAergic Pathway Interaction: Mapping weak allosteric modulations on $GABA_A$ receptors to evaluate their influence on anxiety-related neurological mapping without cross-binding classic benzodiazepine vectors.

Laboratory Storage & Handling Protocols

To shield the stabilized heptapeptide sequence from premature structural fragmentation or breakdown, strictly follow these preservation rules:

• Lyophilized Protection: Store dry, unopened vials deep inside a laboratory freezer at -20°C for long-term storage. Keep environment dark and completely isolated from moisture.
• Reconstitution Protocol: Allow the glass vial to sit undisturbed until it matches ambient room temperature before introducing your fluid. This prevents internal moisture condensation.
• Liquid Phase Management: Following reconstitution with Sterile Bacteriostatic Water, store the liquid solution strictly inside a laboratory refrigerator between 2°C and 6°C. Do not freeze after liquid integration, avoid manual vibration or rapid shaking, and complete all active testing parameters within 14 days.